Retrospective review of cytotoxic chemotherapy and anti-angiogenic combinations in renal cell carcinoma: A single institution experience.

被引：0
|
作者：
Carthon, Bradley Curtis
Tabba, Manal
Ellis, Carla
Harris, Wayne
Bilen, Mehmet Asim
Canter, Daniel
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 06期
关键词：
D O I：
10.1200/JCO.2017.35.6_suppl.523
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
523
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Patient Selection Markers for Anti-angiogenic Agents in Metastatic Renal Cell Carcinoma: Dream or Reality?
    English, P. A.
    Williams, J. A.
    Martini, J. F.
    Motzer, R. J.
    Valota, O.
    Buller, R. E.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 11 - 11
  • [32] TERT Promoter Mutations in Renal Cell Carcinoma: A Single Institution Experience
    Chambers, M.
    Korentzelos, D.
    Quiroga-Garza, G.
    Wald, A.
    Kop, M.
    Mohebnasab, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S137 - S137
  • [33] Nivolumab (nivo) for patients (pts) with metastatic non-clear cell renal cell carcinoma (nccRCC): A single-institution experience.
    Chahoud, Jad
    Campbell, Matthew T.
    Gao, Jianjun
    Zurita, Amado J.
    Shah, Amishi Yogesh
    Msaouel, Pavlos
    Ross, Jeremy Aaron
    Xiao, Lianchun
    Jonasch, Eric
    Sharma, Padmanee
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [34] Chemotherapy with atezolizumab for small cell or neuroendocrine carcinoma of the prostate: A single institution experience
    Wee, Christopher E.
    Costello, Brian A.
    Orme, Jacob J.
    Quevedo, J. Fernando
    Pagliaro, Lance C.
    PROSTATE, 2021, 81 (13): : 938 - 943
  • [35] Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: A retrospective, single-institution study
    Lee, S.
    Yoon, S.
    Shin, S.
    Choi, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [36] Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution study
    Lee, Soohyeon
    Yoon, Sang Hyun
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Choi, Hye Jin
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 1150 - 1157
  • [37] Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution study
    Soohyeon Lee
    Sang Hyun Yoon
    Jun Yong Park
    Do Young Kim
    Sang Hoon Ahn
    Kwang-Hyub Han
    Hye Jin Choi
    Investigational New Drugs, 2012, 30 : 1150 - 1157
  • [38] Therapies and outcomes of non-renal cell carcinoma (non-RCC) neoplasms of the kidney: A single-institution experience.
    Matrana, Marc Ryan
    Rao, Priya
    Atkinson, Bradley J.
    Guo, Charles
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [39] Interest of color Doppler ultrasonography to evaluate a new anti-angiogenic treatment with thalidomide in renal cell carcinoma
    Lassau, N
    Chawi, I
    Rouffiac, V
    Bidault, S
    Escudier, B
    Leclère, J
    BULLETIN DU CANCER, 2004, 91 (7-8) : 629 - 635
  • [40] Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma
    Oudard, Stephane
    Benhamouda, Nadine
    Escudier, Bernard
    Ravel, Patrice
    Tran, Thi
    Levionnois, Emeline
    Negrier, Sylvie
    Barthelemy, Philippe
    Berdah, Jean Francois
    Gross-Goupil, Marine
    Sternberg, Cora N.
    Bono, Petri
    Porta, Camillo
    De Giorgi, Ugo
    Parikh, Omi
    Hawkins, Robert
    Highley, Martin
    Wilke, Jochen
    Decker, Thomas
    Tanchot, Corinne
    Gey, Alain
    Terme, Magali
    Tartour, Eric
    CELLS, 2022, 11 (01)
12345